SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech informs about newspaper publication

12 Feb 2025 Evaluate
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of earlier intimation dated February 11, 2025, regarding declaration of unaudited financial results for the quarter and nine months ended December 31, 2024, Fermenta Biotech has enclosed copy of the newspaper publications published in Business Standard and in Sakal dated February 12, 2025 for reference and record.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

313.15 0.60 (0.19%)
20-Apr-2026 14:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.15
Dr. Reddys Lab 1234.30
Cipla 1232.95
Zydus Lifesciences 938.40
Lupin 2329.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×